179 related articles for article (PubMed ID: 19592503)
21. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
[TBL] [Abstract][Full Text] [Related]
22. Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins.
Liu X; Kramer JA; Swaffield JC; Hu Y; Chai G; Wilson AG
Mutat Res; 2008 May; 653(1-2):63-9. PubMed ID: 18485802
[TBL] [Abstract][Full Text] [Related]
23. GFP assay as a sensitive eukaryotic screening model to detect toxic and genotoxic activity of azaarenes.
Bartos T; Letzsch S; Skarek M; Flegrová Z; Cupr P; Holoubek I
Environ Toxicol; 2006 Aug; 21(4):343-8. PubMed ID: 16841313
[TBL] [Abstract][Full Text] [Related]
24. A genotoxicity test system based on p53R2 gene expression in human cells: assessment of its reactivity to various classes of genotoxic chemicals.
Ohno K; Ishihata K; Tanaka-Azuma Y; Yamada T
Mutat Res; 2008 Oct; 656(1-2):27-35. PubMed ID: 18674635
[TBL] [Abstract][Full Text] [Related]
25. Genotoxicity and carcinogenicity studies of antihypertensive agents.
Brambilla G; Martelli A
Mutat Res; 2006 Mar; 612(2):115-49. PubMed ID: 16458045
[TBL] [Abstract][Full Text] [Related]
26. Genotoxic and carcinogenic effects of gastrointestinal drugs.
Brambilla G; Mattioli F; Martelli A
Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
[TBL] [Abstract][Full Text] [Related]
27. A pre-validation transferability study of the GreenScreen HC GADD45a-GFP assay with a metabolic activation system (S9).
Billinton N; Bruce S; Hansen JR; Hastwell PW; Jagger C; McComb C; Klug ML; Pant K; Rabinowitz A; Rees R; Tate M; Vinggaard AM; Walmsley RM
Mutat Res; 2010 Jul; 700(1-2):44-50. PubMed ID: 20452458
[TBL] [Abstract][Full Text] [Related]
28. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity.
Snyder RD
Environ Mol Mutagen; 2009 Jul; 50(6):435-50. PubMed ID: 19334052
[TBL] [Abstract][Full Text] [Related]
29. Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells.
Mizota T; Ohno K; Yamada T
Mutat Res; 2011 Sep; 724(1-2):76-85. PubMed ID: 21704725
[TBL] [Abstract][Full Text] [Related]
30. Genotoxic and carcinogenic effects of antipsychotics and antidepressants.
Brambilla G; Mattioli F; Martelli A
Toxicology; 2009 Jul; 261(3):77-88. PubMed ID: 19410629
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay.
Jagger C; Tate M; Cahill PA; Hughes C; Knight AW; Billinton N; Walmsley RM
Mutagenesis; 2009 Jan; 24(1):35-50. PubMed ID: 18787182
[TBL] [Abstract][Full Text] [Related]
32. Genotoxicity and carcinogenicity studies of antihistamines.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Arch Toxicol; 2011 Oct; 85(10):1173-87. PubMed ID: 21327970
[TBL] [Abstract][Full Text] [Related]
33. Genotoxic carcinogen or not genotoxic carcinogen? That is the question Re: Olaharski et al., "Validation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds".
Walmsley RM; Billinton N
Mutat Res; 2009 Jan; 672(1):17-9; author reply 20. PubMed ID: 19000775
[No Abstract] [Full Text] [Related]
34. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals.
Brambilla G; Martelli A
Mutat Res; 2009; 681(2-3):209-229. PubMed ID: 18845271
[TBL] [Abstract][Full Text] [Related]
35. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results.
Kirkland DJ; Aardema M; Banduhn N; Carmichael P; Fautz R; Meunier JR; Pfuhler S
Mutagenesis; 2007 May; 22(3):161-75. PubMed ID: 17369606
[TBL] [Abstract][Full Text] [Related]
36. Genotoxicity and carcinogenicity testing of pharmaceuticals: correlations between induction of DNA lesions and carcinogenic activity.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Mutat Res; 2010; 705(1):20-39. PubMed ID: 20206292
[TBL] [Abstract][Full Text] [Related]
37. The involvement of WT1 in the regulation of GADD45a in response to genotoxic stress.
Johnson D; Hastwell PW; Walmsley RM
Mutagenesis; 2013 Jul; 28(4):393-9. PubMed ID: 23476008
[TBL] [Abstract][Full Text] [Related]
38. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens.
Jacobson-Kram D; Contrera JF
Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803
[TBL] [Abstract][Full Text] [Related]
39. An evaluation of the genotoxicity of the antitussive drug Dextromethorphan.
Aardema MJ; Robison SH; Gatehouse D; Johnston G
Regul Toxicol Pharmacol; 2008 Apr; 50(3):285-93. PubMed ID: 18160193
[TBL] [Abstract][Full Text] [Related]
40. Rapid and direct magnetization of GFP-reporter yeast for micro-screening systems.
García-Alonso J; Fakhrullin RF; Paunov VN
Biosens Bioelectron; 2010 Mar; 25(7):1816-9. PubMed ID: 20022481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
